Live feed17:36:52·71dINSIDERFilingvia QuantisnowChief Executive Officer Kulkarni Samarth converted options into 13,250 shares and sold $366,325 worth of shares (6,967 units at $52.58), increasing direct ownership by 3% to 226,106 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.CRSP· CRISPR Therapeutics AGHealth CareOriginal source